hVIVO Services Limited

hVIVO Services Limited is a pioneering clinical research organization based in the UK, specializing in the development and management of human challenge studies. Founded with a vision to accelerate the development of new therapies, hVIVO plays a crucial role in the pharmaceutical and biotechnology sectors by providing innovative solutions for testing the efficacy of vaccines and antiviral treatments.

The company operates state-of-the-art facilities that are equipped to conduct controlled human infection studies, allowing researchers to gather critical data on how diseases affect humans. With a commitment to scientific excellence, hVIVO collaborates with leading academic institutions and industry partners to advance medical research.

• Core Activities:
• Conducting human challenge trials for respiratory and infectious diseases.
• Providing comprehensive clinical trial services, including study design and regulatory support.
• Offering expertise in virology and immunology to enhance research outcomes.

hVIVO’s mission is to improve public health by facilitating the rapid development of effective treatments and vaccines. By leveraging cutting-edge technology and a dedicated team of experts, the company aims to reduce the time and cost associated with bringing new therapies to market.

As a leader in its field, hVIVO is committed to maintaining the highest ethical standards in clinical research, ensuring the safety and well-being of all participants involved in their studies. Through transparency and collaboration, hVIVO strives to build trust with stakeholders and contribute positively to the global healthcare landscape.